Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects

BACKGROUND AND OBJECTIVES: Second-generation antipsychotics (SGAs) for schizophrenia show different risk profiles, whose evidence has been evaluated through comparative reviews on randomized controlled trials (RCTs) and observational studies. METHODS: We performed a systematic review and meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Rognoni, Carla, Bertolani, Arianna, Jommi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004512/
https://www.ncbi.nlm.nih.gov/pubmed/33686614
http://dx.doi.org/10.1007/s40261-021-01000-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004512/
https://www.ncbi.nlm.nih.gov/pubmed/33686614
http://dx.doi.org/10.1007/s40261-021-01000-1

Ejemplares similares